Premium
Insulin‐resistant diabetes during growth hormone therapy in a child with SHORT syndrome
Author(s) -
Verge CF,
Donaghue KC,
Williams PF,
Cowell CT,
Silink M
Publication year - 1994
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1994.tb13142.x
Subject(s) - medicine , diabetes mellitus , growth hormone , insulin resistance , lipoatrophy , insulin , endocrinology , hormone , pediatrics , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , viral load
We report the case of a 13‐year‐old boy with SHORT syndrome, including lipoatrophy and insulin resistance, who developed diabetes mellitus while receiving growth hormone therapy. The diabetes persisted after cessation of exogenous growth hormone but oral hypoglycaemic therapy was successful and could be discontinued eight months later.